×

Synageva agrees to $8.4 billion acquisition

9:08 AM ET Wed, 6 May 2015

Synageva is more than doubling in pre-market after agreeing to be acquired by Alexion Pharmaceuticals for about $8.4 billion in cash and stock. CNBC's David Faber and Jim Cramer discuss.